Heparin and the Reduction of Thrombosis (HART) Trial
Trial ID or NCT#
Heparin is frequently used in central venous catheters (CVCs) in post-operative cardiac patients. It remains unclear if a heparin infusion, compared to a normal saline infusion, prevents thrombosis of CVCs after surgery. This study will answer the question: does a low-dose heparin infusion (10 units/kg/h) prevent thrombosis, compared to a normal saline infusion, in patients less than one year of age after cardiac surgery?
Heparin and Catheter-related Thrombosis in Neonates and Infants Following Cardiac Surgery
- - All infants < 1 year of age undergoing cardiac surgery at Lucile Packard Children's Hospital & #xA
- - Known coagulopathy
- - History of clinically significant bleeding (GI, cranial, pulmonary)
- - Need for therapeutic heparinization
- - ECMO
Contact us to find out if this trial is right for you.
About this Clinical Trial
Your Message Will Go ToDavid Axelrod
Go Back To The Trial